Pacira BioSciences, Inc. - FORM 10-K - EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 - March 31, 2011

Attached files

file filename
10-K - FORM 10-K - Pacira BioSciences, Inc.d10k.htm
EX-31.1 - CERTIFICATION OF PRESIDENT AND CEO PURSUANT TO RULE 13A-14(A) - Pacira BioSciences, Inc.dex311.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) - Pacira BioSciences, Inc.dex312.htm
EX-21.1 - SUBSIDIARIES OF REGISTRANT - Pacira BioSciences, Inc.dex211.htm
EX-32.1 - CERTIFICATION OF PRESIDENT AND CEO PURSUANT TO 18 U.S.C. SECTION 1350 - Pacira BioSciences, Inc.dex321.htm

EXHIBIT 32.2

STATEMENT PURSUANT TO 18 U.S.C. §1350

Pursuant to 18 U.S.C. §1350, the undersigned certifies that this Annual Report on Form 10-K for the period ended December 31, 2010 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of Pacira Pharmaceuticals, Inc.

 

Date: March 31, 2011

      

/s/ James Scibetta

      James Scibetta
      Chief Financial Officer
      (Principal Financial and Accounting Officer)

A signed original of this written statement required by Section 906 has been provided to Pacira Pharmaceuticals, Inc. and will be retained by Pacira Pharmaceuticals, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

Stock widget

Investing forum

Pacira BioSciences, Inc. Reports

Also read